ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014

WHT Participants Get “Phase Out” Help

March 11, 1988

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980